Natera (United States)

Recent publications and citations

Top Concepts

Top subject area publications in last 5 years

Collaboration Analysis

Publications from 2021 to 2026

Latest Publications

Filter IconFilter

Showing 10 of 126 papers

  • Research Article

Abstract PS2-07-26: Clinical performance of Signatera Genome assay for predicting recurrence in patients with breast cancer

  • Feb 17, 2026
  • Clinical Cancer Research
  • Wassim Mchayleh +16
  • Research Article

Abstract PS2-09-20: Circulating Tumor DNA Dynamics and Anatomical Patterns of Relapse Following Curative Therapy in Early-Stage Breast Cancer

  • Feb 17, 2026
  • Clinical Cancer Research
  • D G Stover +8
  • Research Article

Abstract PS4-02-25: Single Institution experience of longitudinal post-surgical circulating tumor DNA monitoring in patients with HER2+ breast cancer

  • Feb 17, 2026
  • Clinical Cancer Research
  • Y Gao +14
  • Research Article

Abstract PD6-07: Ctdna dynamics is most predictive of response in treatment-sensitive response-predictive subtypes of breast cancer: results from the I-SPY2 trial

  • Feb 17, 2026
  • Clinical Cancer Research
  • M Magbanua +23
  • Research Article

Quantification of circulating tumor DNA (ctDNA) using a methylation-based, tissue-free colorectal cancer (CRC) test for the detection of molecular residual disease (MRD).

  • Jan 10, 2026
  • Journal of Clinical Oncology
  • Yoshiaki Nakamura +19
  • Open Access
  • Research Article

Circulating tumor DNA informs clinical practice in patients with recurrent/metastatic gastroesophageal cancers.

  • Jan 01, 2026
  • Cancer
  • Rutika Mehta +13
  • Open Access
  • Research Article

P721: CGG repeat length and AGG interruptions in FMR1: Association with expansion risk in a reproductive carrier screening population

  • Jan 01, 2026
  • Genetics in Medicine Open
  • Victoria Blank +9
  • Open Access
  • Supplementary Content
  • Citations2

Lexicon for Clonal Hematopoiesis in Liquid Biopsy

  • Dec 26, 2025
  • Clinical and Translational Science
  • Robert Tell +21
  • Research Article

CIRCULATING TUMOR DNA (CTDNA) AS A PROGNOSTIC MARKER IN PATIENTS WITH HIGH-RISK ENDOMETRIAL CANCER (HREC)

  • Nov 01, 2025
  • International Journal of Gynecological Cancer
  • Jeffrey How +11
  • Open Access
  • Research Article

308P A comparative benchmarking of large language models (LLMs) for clinical data abstraction from real-world oncology records

  • Nov 01, 2025
  • ESMO Real World Data and Digital Oncology
  • H Guturu +12
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.